zolpidem has been researched along with Nocturnal Wandering in 24 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To identify and analyze postmarketing cases of complex sleep behaviors (CSBs) resulting in serious injuries, including death, associated with eszopiclone, zaleplon, or zolpidem (Z-drugs)." | 9.05 | Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death. ( Chan, V; Croteau, D; Harbourt, K; Nevo, ON; Zhang, R, 2020) |
| "However, zolpidem-induced somnambulism and amnesic sleep-related behavioral problems were begun to be reported in literature but no systemic investigation has been undertaken in non-Western cultures." | 5.35 | Zolpidem-induced amnesia and somnambulism: rare occurrences? ( Chen, CC; Chung, W; Liu, JK; Tang, TC; Tsai, JH; Wang, SY; Yang, P, 2009) |
| "To identify and analyze postmarketing cases of complex sleep behaviors (CSBs) resulting in serious injuries, including death, associated with eszopiclone, zaleplon, or zolpidem (Z-drugs)." | 5.05 | Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death. ( Chan, V; Croteau, D; Harbourt, K; Nevo, ON; Zhang, R, 2020) |
| "A 47-year-old white man with a history of bipolar disorder was being maintained on citalopram 40 mg once daily and zolpidem 5 mg at bedtime." | 3.72 | Somnambulism due to probable interaction of valproic acid and zolpidem. ( Bhatia, SC; Petty, F; Ramaswamy, S; Sattar, SP, 2003) |
| "Medications that trigger sleepwalking may inadvertently put the patient at risk of injury to themselves and/or others, and contribute to poor treatment adherence." | 2.58 | Medication induced sleepwalking: A systematic review. ( Kohler, M; Stallman, HM; White, J, 2018) |
| "Zolpidem is a widely prescribed nonbenzodiazepine hypnotic medication available in the United States since 1992." | 2.47 | "I did what?" Zolpidem and the courts. ( Binder, RL; Daley, C; McNiel, DE, 2011) |
| "Zolpidem is a hypnotic which acts at the GABAA receptor and is indicated for short-term insomnia." | 2.45 | Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. ( Chesson, AL; Hoque, R, 2009) |
| "It is proposed that zolpidem-induced sleepwalking can be explained by the desensitization of GABAergic receptors located on serotonergic neurons." | 1.37 | Desensitization of GABAergic receptors as a mechanism of zolpidem-induced somnambulism. ( Juszczak, GR, 2011) |
| "Zolpidem is a hypnotic drug used in sleep disorders." | 1.36 | [Sleep related eating disorders as a side effect of zolpidem]. ( Alvarez, F; Cristiano, E; Martínez, OA; Reisin, RC; Valiensi, SM, 2010) |
| "However, zolpidem-induced somnambulism and amnesic sleep-related behavioral problems were begun to be reported in literature but no systemic investigation has been undertaken in non-Western cultures." | 1.35 | Zolpidem-induced amnesia and somnambulism: rare occurrences? ( Chen, CC; Chung, W; Liu, JK; Tang, TC; Tsai, JH; Wang, SY; Yang, P, 2009) |
| "Zolpidem is an imidazopyridine agent indicated for the short-term treatment of insomnia." | 1.33 | One rare side effect of zolpidem--sleepwalking: a case report. ( Dollear, M; Muthukrishnan, SR; Yang, W, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 11 (45.83) | 29.6817 |
| 2010's | 9 (37.50) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Harbourt, K | 1 |
| Nevo, ON | 1 |
| Zhang, R | 1 |
| Chan, V | 1 |
| Croteau, D | 1 |
| Stallman, HM | 1 |
| Kohler, M | 1 |
| White, J | 1 |
| Suzuki, H | 1 |
| Hibino, H | 1 |
| Inoue, Y | 1 |
| Mikami, A | 1 |
| Matsumoto, H | 1 |
| Mikami, K | 1 |
| Tsai, JH | 1 |
| Yang, P | 1 |
| Chen, CC | 1 |
| Chung, W | 1 |
| Tang, TC | 1 |
| Wang, SY | 1 |
| Liu, JK | 1 |
| Siddiqui, F | 1 |
| Osuna, E | 1 |
| Chokroverty, S | 1 |
| Hoque, R | 1 |
| Chesson, AL | 1 |
| Valiensi, SM | 1 |
| Cristiano, E | 1 |
| Martínez, OA | 1 |
| Reisin, RC | 1 |
| Alvarez, F | 1 |
| Pressman, MR | 1 |
| Juszczak, GR | 1 |
| Marshall, NS | 1 |
| Buchanan, PR | 1 |
| Daley, C | 1 |
| McNiel, DE | 1 |
| Binder, RL | 1 |
| Poceta, JS | 1 |
| Sattar, SP | 1 |
| Ramaswamy, S | 1 |
| Bhatia, SC | 1 |
| Petty, F | 1 |
| Yanes Baonza, M | 1 |
| Ferrer García-Borrás, JM | 1 |
| Cabrera Majada, A | 1 |
| Sánchez González, R | 1 |
| Lange, CL | 1 |
| Yang, W | 1 |
| Dollear, M | 1 |
| Muthukrishnan, SR | 1 |
| Barrett, J | 1 |
| Underwood, A | 1 |
| Gorman, C | 1 |
| Cartwright, R | 1 |
| Iruela, LM | 1 |
| Mendelson, WB | 1 |
| Harazin, J | 1 |
| Berigan, TR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of High-altitude Sleep Disturbance: A Double-blind Comparison of Temazepam Versus Acetazolamide.[NCT01519544] | 34 participants (Actual) | Interventional | 2012-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for zolpidem and Nocturnal Wandering
| Article | Year |
|---|---|
Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death.
Topics: Acetamides; Adult; Adverse Drug Reaction Reporting Systems; Aged; Drug Labeling; Eszopiclone; Female | 2020 |
Medication induced sleepwalking: A systematic review.
Topics: Antidepressive Agents; GABA-A Receptor Agonists; Humans; Pyridines; Somnambulism; Zolpidem | 2018 |
Drugs for Insomnia.
Topics: Acetamides; Animals; Eszopiclone; Humans; Hypnotics and Sedatives; Plant Preparations; Pyridines; Py | 2015 |
Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.
Topics: Automobile Driving; Brain; Brain Mapping; Feeding and Eating Disorders; Female; Fluorodeoxyglucose F | 2009 |
Sleep driving: sleepwalking variant or misuse of z-drugs?
Topics: Accidents, Traffic; Automobile Driving; Azabicyclo Compounds; Humans; Hypnotics and Sedatives; Piper | 2011 |
"I did what?" Zolpidem and the courts.
Topics: Dangerous Behavior; Forensic Medicine; Humans; Hypnotics and Sedatives; Pyridines; Risk Factors; Som | 2011 |
18 other studies available for zolpidem and Nocturnal Wandering
| Article | Year |
|---|---|
Benefits of switching to suvorexant for mild primary insomnia when sleepwalking episodes occur during zolpidem treatment.
Topics: Adult; Azepines; Female; GABA-A Receptor Agonists; Humans; Orexin Receptor Antagonists; Sleep Initia | 2017 |
Zolpidem-induced amnesia and somnambulism: rare occurrences?
Topics: Adult; Amnesia; Female; Health Surveys; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pyridine | 2009 |
Writing emails as part of sleepwalking after increase in Zolpidem.
Topics: Adult; Electronic Mail; Female; Humans; Hypnotics and Sedatives; Pyridines; Sleep Initiation and Mai | 2009 |
[Sleep related eating disorders as a side effect of zolpidem].
Topics: Adult; Aged; Feeding and Eating Disorders; Female; GABA-A Receptor Agonists; Humans; Hypnotics and S | 2010 |
Desensitization of GABAergic receptors as a mechanism of zolpidem-induced somnambulism.
Topics: GABA-A Receptor Agonists; Humans; Hypnotics and Sedatives; Models, Biological; Pyridines; Receptors, | 2011 |
Z drug zombies: parasomnia, drug effect or both?
Topics: Automobile Driving; Azabicyclo Compounds; Humans; Hypnotics and Sedatives; Piperazines; Pyridines; S | 2011 |
Zolpidem ingestion, automatisms, and sleep driving: a clinical and legal case series.
Topics: Adult; Aged; Automatism; Automobile Driving; Female; Follow-Up Studies; Headache; Humans; Hypnotics | 2011 |
Somnambulism due to probable interaction of valproic acid and zolpidem.
Topics: Bipolar Disorder; Citalopram; Depression; Drug Interactions; Drug Therapy, Combination; Humans; Male | 2003 |
[Sleep-walking linked to zolpidem].
Topics: Aged; Humans; Hypnotics and Sedatives; Male; Pyridines; Sleep; Somnambulism; Zolpidem | 2003 |
Medication-associated somnambulism.
Topics: Adolescent; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Hypnotics and Sedatives; Pyri | 2005 |
One rare side effect of zolpidem--sleepwalking: a case report.
Topics: Humans; Hypnotics and Sedatives; Male; Middle Aged; Pyridines; Sleep Initiation and Maintenance Diso | 2005 |
Perchance to...eat?
Topics: Feeding Behavior; Humans; Hypnotics and Sedatives; Pyridines; Somnambulism; United States; Zolpidem | 2006 |
Sleeping-pill puzzler.
Topics: Humans; Hypnotics and Sedatives; Pyridines; Sleep Wake Disorders; Somnambulism; United States; Zolpi | 2006 |
Putting "sleepdriving" and new safety warning in perspective.
Topics: Automobile Driving; Drug Labeling; Humans; Hypnotics and Sedatives; Indenes; Middle Aged; Psychoses, | 2007 |
Re: Pressman, M. Response to Rosalind Cartwright's letter to the editor. Sleep Medicine Reviews 2007; 11(4): 329-333.
Topics: Aggression; Animals; Arousal; Delta Rhythm; Expert Testimony; Genetic Predisposition to Disease; Hum | 2008 |
Zolpidem and sleepwalking.
Topics: Humans; Hypnotics and Sedatives; Pyridines; Somnambulism; Zolpidem | 1995 |
Sleepwalking associated with zolpidem.
Topics: Adult; Humans; Hypnotics and Sedatives; Male; Pyridines; Somnambulism; Zolpidem | 1994 |
Zolpidem tartrate and somnambulism.
Topics: Humans; Hypnotics and Sedatives; Male; Middle Aged; Military Personnel; Polysomnography; Pyridines; | 1999 |